Navigation Links
GlaxoSmithKline Presents Innovative Neuroscience Pipeline
Date:12/13/2007

etabolic-related effects, such as weight gain and blood lipid increases, which are common side effects of antipsychotic treatments. In one study, patients receiving 60mg daily of '812 experienced a decrease of 1.0kg in body weight, which was a statistically significant change compared to patients receiving placebo or olanzapine, whose body weight increased by 0.9kg and 2.2kg respectively. In addition, patients receiving '812 did not show an increase in triglycerides or cholesterol levels.

The development program for '812 continues with phase IIb trials, which are expected to demonstrate benefits versus two commonly used treatments for schizophrenia. These trials are expected to start in 2008.

742457 - A novel treatment to delay the symptoms of Alzheimer's disease:

Alzheimer's disease is a devastating neurological condition, with significant consequences on the quality of life for sufferers and their care givers. GSK has a broad program of research ongoing in Alzheimer's disease, including 742457, a novel treatment that selectively targets the 5HT6 receptors concentrated within the brain. These receptors are associated with learning and memory. Currently available treatments, such as cholinesterase inhibitors, are not brain specific and alter the cholinergic system throughout the body leading to possible side effects, particularly gastrointestinal side effects.

Results from a phase II placebo-controlled dose-ranging study in 371 patients demonstrated that over a 24-week treatment period, patients receiving 35mg doses of '457 showed statistically significant improvements in global function compared to placebo as measured by the CIBIC+. The CIBIC+ is a clinician-rated scale which assesses global improvement, including input from patients' care givers. All doses of '457 appeared generally well tolerated, with a low overall incidence of adverse events.

Another phase II trial comparing 15-35mg of '457, and 5-10mg of donepezil, a commonly
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. Updated GOLD report presents new understandings in diagnosis, treatment and prevention of COPD
11. The Art Of Maternity(TM) at Destination Maternity(R) Presents A Sacred Passage Into Motherhood; the Art of Belly Masking to Belly Casting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... 2014 Ticket Down is a ... for her 2015 “Honeymoon Tour.” This well-known ticket exchange ... savings. , In early 2015, fans will have a chance ... across North America. Twenty-one-year-old Ariana Grande will hit the road ... her to 25 cities across the United States and Canada. ...
(Date:9/20/2014)... New York, New York (PRWEB) September 20, 2014 ... of power morcellators ( http://www.injurybeacon.com/power-morcellator/ ) in ... notes that yet another insurer has announced plans ... a statement posted on its website last month, ... such procedures effective November 1, 2014. The insurer ...
(Date:9/20/2014)... Recently, Best Cheap Hosting USA (best-cheap-hosting-usa.com), ... new website. The new site provides the latest ... for customers. Here, people can find a lot ... Also, it has recommended some excellent web hosting ... the great web hosting suppliers, InMotion ( http://www.best-cheap-hosting-usa.com/go/InMotion/ ...
(Date:9/20/2014)... dentists have advised their patients against drinking coffee and wine. ... that advice and changing his stance after considering two recent ... oral health. “There’s good news and great news,” says Dr. ... protecting against gum disease, and red wine can help fight ... the September 2014 issue of Boston University School of ...
(Date:9/20/2014)... September 20, 2014 Recently, UWDress.com, an ... and women’s special occasion outfits, has launched a special ... company’s prom outfits are popular among worldwide clients. Now, ... wholesale prom dresses on its website. , ... customers from around the world. Great custom made items ...
Breaking Medicine News(10 mins):Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 3Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 2Health News:As Power Morcellator Concerns Grow, Bernstein Liebhard LLP Notes Another Insurer’s Decision to Drop Coverage for Uterine Morcellation 3Health News:Best Cheap Hosting USA Launches Its New Website And Recommends InMotion To Worldwide People 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 3Health News:Discounted 2014 Prom Dresses Provided By Innovative Company UWDress.com 2
... predictive tools, but not all agree , TUESDAY, Sept. 29 (HealthDay ... a milder interruption of blood flow to the brain, called a ... because of that, the researchers conclude, such an attack is ... implication of this study is that we cannot rely on the ...
... ... by a national nutrition company…A FREE 4 Week Personal Nutrition Plan guaranteed to ... ... boldest move ever constructed by a respected national nutrition company, Max Muscle Sports Nutrition ...
... ... (HFO) has added a new online continuing education (CE/CEU) course entitled ... nationally-approved CE courses for mental health professionals, nurses and allied healthcare ... that may occur close to death in a situation of physical ...
... ... Dr. Katz , ... (PRWEB) September 29, 2009 -- Foot pain and foot care come in all ... and ankle pain and are growing frustrated with continuous visits to their doctors. One physician, ...
... Organization (WHO) estimated that globally 400 million adults were obese, ... or greater. WHO projects that by 2015 there will ... is considered to be one of the greatest risk factors ... loss of joint cartilage. Researchers from Duke University, supported ...
... ... , ... 28, 2009 -- Keystone Mercy Health Plan , a member of the AmeriHealth ... members of the press to join Lt. General Russel Honoré , who is best known ...
Cached Medicine News:Health News:Mini-Stroke Found to Precede 1 in 8 Strokes 2Health News:Mini-Stroke Found to Precede 1 in 8 Strokes 3Health News:President Announces Free Health Plan 2Health News:President Announces Free Health Plan 3Health News:New Online Continuing Education Course on Near-Death Experience Added to HealthForumOnline's Library for Mental Health Professionals 2Health News:New Online Continuing Education Course on Near-Death Experience Added to HealthForumOnline's Library for Mental Health Professionals 3Health News:New Online Continuing Education Course on Near-Death Experience Added to HealthForumOnline's Library for Mental Health Professionals 4Health News:New Online Continuing Education Course on Near-Death Experience Added to HealthForumOnline's Library for Mental Health Professionals 5Health News:Dr. Marc Katz, Leading Podiatric Surgeon Adds High Powered Color Ultrasound To Cryosurgery Procedures and Treatments 2Health News:Study suggests obesity alone does not cause knee osteoarthritis in mice 2Health News:Katrina Hero, Lt. General Russel Honor (Ret.), to Speak on H1N1 Flu Preparedness at Press Briefing Following AmeriHealth Mercy/PerformRx Conference 2
(Date:9/19/2014)... Mass. , Sept. 19, 2014  Pressure ... today announced it has received and approved all ... HT48 instruments and has begun to manufacture the ... first instrument will be ready for shipment by ... built and released at a rate of about ...
(Date:9/19/2014)... 19, 2014  Over 200 runners participated in the ... the Radiation Oncology Institute (ROI), hosted by Radiation Business ... Park in San Francisco.  "Donations are ... of Radiation Business Solutions, "but at this point, ... $70,000 for the ROI this year. This surpasses last ...
(Date:9/19/2014)... PHILADELPHIA , Sept. 19, 2014  PCI ... Services International (Biotec).  Biotec is a leading provider ... Services headquartered in Bridgend, Wales ... .  The addition significantly expands PCI,s presence in ... medicinal products by adding packaging, storage and distribution ...
Breaking Medicine Technology:Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6
... - Strategic Collaboration with the Gynecologic Oncology Group ... Sciences, Inc. today,announced it has expanded its clinical ... 2 study of its lead product candidate,BSI-201. The ... inhibitor in the company,s DNA repair portfolio, for ...
... Updated Results Showing a 20% Reduction in the Risk, ... Disease Free Survival at ... Surgery -, BRIDGEWATER, N.J., May 28 Sanofi-aventis U.S.,announced ... supplemental new drug application (sNDA) to include six-year overall,survival analysis ...
Cached Medicine Technology:BiPar Sciences Expands Clinical Development of BSI-201, A Novel PARP Inhibitor, With Phase 2 Trial in Uterine Cancer 2New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 2New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 3New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 4
Double-ended. Designated most popular model or size....
Double-ended. Sharp and blunt 6.5 mm tips. Designated most popular model or size....
2 mm tip....
Octagonal handle. 3 mm wide....
Medicine Products: